N-ethyl-N-nitrosourea mutagenesis: boarding the mouse mutant express.
In the mouse, random mutagenesis with N-ethyl-N-nitrosourea (ENU) has been used since the 1970s in forward mutagenesis screens. However, only in the last decade has ENU mutagenesis been harnessed to generate a myriad of new mouse mutations in large-scale genetic screens and focused, smaller efforts. The development of additional genetic tools, such as balancer chromosomes, refinements in genetic mapping strategies, and evolution of specialized assays, has allowed these screens to achieve new levels of sophistication. The impressive productivity of these screens has led to a deluge of mouse mutants that wait to be harnessed. Here the basic large- and small-scale strategies are described, as are the basics of screen design. Finally, and importantly, this review describes the mechanisms by which such mutants may be accessed now and in the future. Thus, this review should serve both as an overview of the power of forward mutagenesis in the mouse and as a resource for those interested in developing their own screens, adding onto existing efforts, or obtaining specific mouse mutants that have already been generated.
Cordes
Sabine P
SP
Samuel Lunenfeld Research Institute, Room 865, Mt. Sinai Hospital, Toronto, Ontario M5G 1X5, Canada. cordes@mshri.on.ca
D000477:Alkylating Agents / Q000494:pharmacology*; D000818:Animals; D002874:Chromosome Mapping; D005038:Ethylnitrosourea / Q000494:pharmacology*; D005260:Female; D005820:Genetic Testing / Q000379:methods; D008297:Male; D051379:Mice; D008817:Mice, Mutant Strains / Q000235:genetics*; D016297:Mutagenesis, Site-Directed / Q000379:methods*; D009153:Mutagens / Q000494:pharmacology*
D000477:Alkylating Agents; D009153:Mutagens; D005038:Ethylnitrosourea